Nitroglycerin induced hypotension will maintain CBF in hypertensive rats

Area of Science:

• Cardiovascular Physiology
• Neuroscience
• Pharmacology

Background:

• Spontaneously hypertensive rats (SHR) and Wistar Kyoto controls (WKY) are established models for studying hypertension and normotension.
• Intravenous nitroglycerin (NTG) is a potent vasodilator with known cardiovascular effects.
• Understanding NTG's impact on cerebral blood flow (CBF) is crucial for managing cerebrovascular conditions.

Purpose of the Study:

• To investigate the cerebrovascular effects of intravenous nitroglycerin (NTG) infusions in spontaneously hypertensive rats (SHR) and Wistar Kyoto controls (WKY).
• To determine if NTG maintains cerebral blood flow (CBF) during induced hypotension in these models.

Main Methods:

• Four-month-old SHR and WKY rats were anesthetized and ventilated.
• Cerebral blood flow (CBF) was measured using radioactive microspheres during intravenous infusions.
• Blood pressure was modulated using intravenous saline (controls) or NTG infusions.

Main Results:

• In control rats receiving saline, blood pressure and CBF remained stable.
• Intravenous NTG infusions decreased blood pressure in both SHR and WKY rats.
• Despite reduced blood pressure, cerebral blood flow (CBF) was maintained or increased by NTG in both hypertensive and normotensive rats.
• No significant difference in response was observed between SHR and WKY rats.

Conclusions:

• Nitroglycerin (NTG) exerts direct cerebrovasodilating effects.
• NTG effectively maintains adequate cerebral blood flow (CBF) in both hypertensive and normotensive subjects, even when blood pressure falls below 50 torr.
• These findings support the use of NTG in managing conditions where maintaining cerebral perfusion is critical.